Scott Robertson is the chief business and financial officer of DICE Therapeutics. Prior to DICE, he served as business development director for DuPont Pioneer, with responsibility for mergers & acquisitions and strategic partnerships. He also held the position of portfolio manager with DuPont Ventures, where he focused on strategic investment opportunities in crop genetics and precision agriculture. Prior to joining DuPont, Scott was an investment professional at MPM Capital, a life sciences-dedicated venture capital fund, and previous to that he was a member of the healthcare investment banking teams at Merrill Lynch & Co. and Thomas Weisel Partners.
Scott holds a B.S. in business administration from the University of Southern California and an MBA from the Haas School of Business at the University of California, Berkeley.